Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3293858 | Gastroenterology | 2012 | 12 Pages |
Abstract
Twenty-four weeks of teduglutide treatment was generally well tolerated in patients with SBS-IF. Treatment with teduglutide reduced volumes and numbers of days of parenteral support for patients with SBS-IF; ClinicalTrials.gov Number, NCT00798967.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Palle B. Jeppesen, Marek Pertkiewicz, Bernard Messing, Kishore Iyer, Douglas L. Seidner, Stephen J.D. O'keefe, Alastair Forbes, Hartmut Heinze, Bo Joelsson,